Register here

Module 1: Biosimilars & Biologics: An Introduction 
ACPE Number: 0633-0000-22-019-H01-P 

This first course entitled "Introduction to Biologics and Biosimilars" covers foundational content in Biologics and Biosimilars. This is the first of seven courses in the Biosimilars Continuing Education Series. Your course facilitator for "Introduction to Biologics and Biosimilars" is Professor Phil Schneider. 

Learning Objectives:  

1. Describe the basic science and manufacturing of biologic medicines 

2. Define biosimilars and explore how they differ from genetic drugs for purposes of patient care, pharmacovigilence, and pharmacy practice. 

3. List key regulatory and policy considerations including interchangeability and substitution policy. 

Module 2: Biosimilars - Substitution and Interchangeability  
ACPE Number: 0633-0000-22-020-H01-P 

This second course in the Biosimilars Continuing Education Series entitled "Biosimilars - Substitution and Interchangeability" will examine U.S. biosimilar substitution policy and practices and will compare these with those of other countries. Physician and patient concerns with these practices will also be discussed. This is the second of seven courses in the Biosimilars Continuing Education Series. Your course facilitator for "Biosimilars - Substitution and Interchangeability" is Professor Phil Schneider. 

Learning Objectives: 

1. Discuss patient and physician concerns with third-party substitution of biosimilars. 

2. Explain the concept of interchangeability- how it addresses physician and patient concerns; and what it means for pharmacy-level substitution of biologics. 

3. Discuss the current status of US biosimilar substitution policy and its evolution at the state level. 

4. Compare the US approach to automatic substitution with those of other countries including Australia, Canada, and those in Western and Eastern Europe 

Module 3: Biologic and Biosimilar Pharmacovigilance 
ACPE Number: 0633-0000-22-021-H01-P 

This third course in the Biosimilars Continuing Education Series entitled "Biologic and Biosimilar Pharmacovigilance" will highlight the unique pharmacovigilance challenges that biosimilars pose and examine the various approaches regulators in the U.S. and elsewhere have implemented to address these challenges. This is the third of seven courses in the Biosimilars Continuing Education Series. Your course facilitator for "Biologic and Biosimilar Pharmacovigilance" is Professor Phil Schneider. 

Learning Objectives:  

1. Define pharmacovigilance 

2. Explain the role of the DFA in relation to Biosimilars 

3. Identify unique pharmacovigilance challenges biosimilars pose 

4. Identify globally existing problems with pharmacovigilance programs 

5. Recognize ways to address existing problems with pharmacovigilance programs 

The APhA Pharmacy-Based Cardiovascular Disease Risk Management certificate training program explores the pharmacist’s role in cardiovascular disease risk management. This practice-based activity is the first step for pharmacists interested in learning the essential skills to successfully assess risk, promote cardiovascular disease prevention, and encourage patient adherence to therapy.

This program consists of 12 hours (1.2 CEUs) of continuing pharmacy education credit for the self-study modules and 8 hours (0.8 CEUs) of continuing pharmacy education credit for the live session. Successful completion is defined as a score of 70% or better on both the self-study and live seminar assessments.

At the end of the seminar, you will be given directions to complete your final assessment, claim your credit, and to print your certificate of achievement. This can be completed once you have returned home, but within a deadline that will be provided at the conclusion of the seminar.

The American Pharmacists Association (APhA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

For a complete list of learning objectives, technology requirements, and for all APhA accreditation information and policies, please visit APhA’s website.

APhA’s The Pharmacist and Patient-Centered Diabetes Care certificate training program is an intensive educational experience designed to equip pharmacists with the knowledge, skills, and confidence needed to provide effective, evidence-based diabetes care. Five self-study modules provide comprehensive instruction in current diabetes concepts and standards of care.

The live seminar incorporates case studies and hands-on skills training focused on the situations most likely to be encountered—as well as the services most needed—in community and ambulatory care practice settings.

Participants will gain experience evaluating and adjusting drug therapy regimens for patients with type 1 and type 2 diabetes, counseling patients about lifestyle interventions, analyzing and interpreting self-monitoring of blood glucose results, and assessing the overall health status of patients to identify needed monitoring and interventions.

The American Pharmacists Association (APhA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

For a complete list of learning objectives and for all APhA accreditation information and policies, please visit APhA’s website.

APhA's Pharmacy-Based Immunization Delivery certificate training program is a continuing pharmacy education activity based on national educational standards for immunization training from the Centers for Disease Control and Prevention. This program is designed to educate pharmacists about the professional opportunities for vaccine advocacy and administration. The practice-based curriculum represents a fusion of science and clinical pharmacy. The program seeks to foster the implementation of interventions that will promote disease prevention and public health.

This program consists of three components: 12 hours (1.2 CEU) of self-study modules with case studies and an assessment exam, as well as 8.0 hours (0.8 CEU) live seminar with final exam and a hands-on assessment of intramuscular and subcutaneous injection technique. Successful completion is defined as a score of 70% or better on both the self-study and live seminar assessments.

The purpose of this 20 credit hour certificate training program is to prepare pharmacists with comprehensive knowledge, skills and resources necessary to provide immunization services to patients across the life span.

The American Pharmacists Association (APhA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

For a complete list of learning objectives, technology requirements and for all APhA accreditation information and policies, please visit APhA’s website.

APhA's Delivering Medication Therapy Management (MTM) Services certificate training program explores the pharmacist’s role in providing MTM services to patients. Pharmacists have a tremendous opportunity to receive reimbursement for monitoring and improving medication use in patients with complex medication regimens.

This practice-based activity teaches pharmacists the essential skills necessary to become a successful MTM practitioner. The program will enhance pharmacists’ clinical expertise in evaluating complicated medication regimens, identifying medication-related problems, and making recommendations to patients, caregivers, and health care professionals.

The American Pharmacists Association (APhA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

For a complete list of learning objectives and for all APhA accreditation information and policies, please visit APhA’s website.

The APhA Pharmacy-Based Travel Health Services certificate training program is an advanced competency training (ACT) program that explores the pharmacist’s role in providing travel health services to patients. This application-based activity is the first step for pharmacists interested in learning the essential skills necessary to successfully provide travel health services.

This program consists of two components: 6.0 hours (0.6 CEU) web based self-study modules with case studies and an assessment exam as well as 4.0 hours (0.4 CEU) live seminar with an assessment exam. Successful completion is defined as a score of 70% or better on both the self-study and live seminar assessments.

Program pre-requisite: Pharmacists who have completed the APhA Pharmacy-Based Immunization Delivery certificate training program and received a Certificate of Achievement or have previously completed an immunization training program and are authorized to provide immunizations in the state in which they practice.

The American Pharmacists Association (APhA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

For a complete list of learning objectives and for all APhA accreditation information and policies, please visit APhA’s website.

The Ohio State University College of Pharmacy is hosting the Community Pharmacy-Based Point-of-Care Testing Certificate Program. This Continuing Pharmacy Education (CPE) program is designed specifically for community pharmacy, academia and pharmacy association staff.

The program offers up to eight hours of live CPE credit as well as 12 hours of home study credit.

Participants gain skills necessary to develop and implement a collaborative testing program for influenza, Group A streptococcus, HIV and hepatitis C. Visit the NACDS website for more information.